Share Search
Visit the Share Search
Poolbeg Pharma Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating Profit / Loss | -6.03 | -6.37 | -5.04 | -4.99 | -2.34 |
| Net Interest | 0.25 | 0.43 | -4.50 | 0.21 | n/a |
| Pre Tax Profit | -5.77 | -5.94 | -3.93 | -4.78 | -2.34 |
| Post Tax Profit | -5.70 | -5.79 | -3.93 | -4.69 | -2.34 |
| Profit for the Period | -5.70 | -5.79 | -3.93 | -4.69 | -2.34 |
| Equity Holders of Parent Company | -5.70 | -5.79 | -3.93 | -4.69 | -2.34 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -0.94p | -1.16p | -0.79p | -0.94p | -0.74p |
| Earnings per Share (Diluted) | -0.94p | -1.16p | -0.79p | -0.94p | -0.74p |
| Earnings per Share (Adjusted) | -0.94p | -1.16p | -0.79p | -0.94p | -0.74p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -0.94p | -1.16p | -0.79p | -0.94p | -0.74p |
| Earnings per Share (Diluted) | -0.94p | -1.16p | -0.79p | -0.94p | -0.74p |
| Earnings per Share (Adjusted) | -0.94p | -1.16p | -0.79p | -0.94p | -0.74p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | 1.67 | 1.68 | 1.93 | 2.13 | 1.56 |
| Property, Plant and Equipment | n/a | n/a | n/a | n/a | n/a |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | 1.67 | 1.68 | 1.93 | 2.13 | 1.56 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | n/a | n/a | n/a | 0.96 | 0.51 |
| Cash at Bank and in Hand | 0.56 | 0.74 | 1.33 | 16.19 | 20.95 |
| Current Asset Investments | 7.71 | 7.82 | 12.17 | n/a | n/a |
| Other Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 8.27 | 8.56 | 13.50 | 17.16 | 21.45 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 9.94 | 10.25 | 15.43 | 19.29 | 23.02 |
| Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 1.34 | 0.97 | 0.99 | 0.97 | 0.44 |
| Total Current Liabilities | 1.34 | 0.97 | 0.99 | 0.97 | 0.44 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Net Assets | 8.60 | 9.27 | 14.44 | 18.32 | 22.58 |
| Capital and Reserves | |||||
| Share Capital | 0.14 | 0.10 | 0.10 | 0.10 | 0.10 |
| Share Premium Account | 27.54 | 23.10 | 23.10 | 23.10 | 23.10 |
| Other Reserves | 3.36 | 2.82 | 2.19 | 2.15 | 1.72 |
| Retained Earnings | -22.44 | -16.74 | -10.95 | -7.02 | -2.34 |
| Shareholders Funds | 8.60 | 9.27 | 14.44 | 18.32 | 22.58 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 8.60 | 9.27 | 14.44 | 18.32 | 22.58 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | n/a% | n/a% | n/a% | n/a% | n/a% |
| Return on Capital Employed | -87.01% | -83.96% | 4.59% | -30.80% | -11.11% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 0.98p | 1.08p | 1.77p | 2.30p | 2.98p |